This inventor holds 2 USPTO granted patents. Top assignees: British Technology Group Limited, Isis Innovation Limited. Active years: 1998-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, GB (1998)
- Oxford, GB (2013)
Company Filing History:
Years Active: 1998-2013
Title: Masahide Tone: Innovator in Antibody Technology
Introduction
Masahide Tone is a distinguished inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody variants. With a total of 2 patents to his name, Tone's work has the potential to impact therapeutic approaches in medicine.
Latest Patents
One of Tone's latest patents involves antibody variants. This invention relates to a modified version of a therapeutic antibody that has an affinity for a cell-surface antigen. The modified antibody exhibits reduced affinity for the antigen compared to the therapeutic antibody due to specific modifications. This innovative approach is capable of inducing immunological tolerance to the therapeutic antibody. Additionally, the invention includes a method for inducing this tolerance by administering the modified antibody to patients. Another notable patent is for the recombinant CDw52 antigen, which further showcases his expertise in antibody technology.
Career Highlights
Throughout his career, Masahide Tone has worked with prominent organizations such as Isis Innovation Limited and British Technology Group Limited. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.
Collaborations
Tone has collaborated with notable individuals in the field, including Herman Waldmann and Mark Raymond Frewin. These partnerships have likely enriched his research and led to innovative advancements in antibody technology.
Conclusion
Masahide Tone's contributions to the field of biotechnology, particularly through his patents on antibody variants, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
